BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
UBS
Argus Health
Medtronic
Julphar
Boehringer Ingelheim
Fish and Richardson
Chinese Patent Office
Covington

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,308,195

« Back to Dashboard

Which drugs does patent 9,308,195 protect, and when does it expire?

Patent 9,308,195 protects DOCETAXEL and is included in one NDA.

This patent has fifteen patent family members in fifteen countries.
Summary for Patent: 9,308,195
Title:Non-aqueous taxane formulations and methods of using the same
Abstract: Non-aqueous, ethanol-free taxane formulations are provided. Formulations of embodiments of the invention include a taxane, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid component, wherein the organic acid component is soluble in the non-aqueous solvent and the amount by weight of non-ionic surfactant is equal to or greater than the amount by weight of non-aqueous solvent. Also provided are methods of using the formulations, as well as kits that include the formulations. Non-aqueous, ethanol-free docetaxel formulations are provided. Formulations of embodiments of the invention include docetaxel, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid which is soluble in the non-aqueous solvent and is substantially free of any conjugate base. Also provided are methods of using the formulations, as well as kits that include the formulations.
Inventor(s): Nabeta; Kiichiro (Tokyo, JP)
Assignee: Teikoku Pharma USA, Inc. (San Jose, CA)
Application Number:14/564,384
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Device;

Drugs Protected by US Patent 9,308,195

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Eagle Pharms DOCETAXEL docetaxel SOLUTION;IV (INFUSION) 205934-001 Dec 22, 2015 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Eagle Pharms DOCETAXEL docetaxel SOLUTION;IV (INFUSION) 205934-002 Dec 22, 2015 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Eagle Pharms DOCETAXEL docetaxel SOLUTION;IV (INFUSION) 205934-003 Dec 22, 2015 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 9,308,195

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,940,786 Non-aqueous taxane nanodispersion formulations and methods of using the same ➤ Subscribe
9,763,880 Non-aqueous taxane formulations and methods of using the same ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 9,308,195

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 2015534558 ➤ Subscribe
Australia 2013327563 ➤ Subscribe
Canada 2885930 ➤ Subscribe
China 104822262 ➤ Subscribe
European Patent Office 2903435 ➤ Subscribe
Hong Kong 1210665 ➤ Subscribe
India 2661DEN2015 ➤ Subscribe
South Korea 20150066542 ➤ Subscribe
Mexico 2015003824 ➤ Subscribe
Philippines 12015500681 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Covington
McKesson
Accenture
UBS
Federal Trade Commission
McKinsey
Teva
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot